These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 9774439
1. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. Verdier F, Chrétien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C, Mayeux P. J Biol Chem; 1998 Oct 23; 273(43):28185-90. PubMed ID: 9774439 [Abstract] [Full Text] [Related]
3. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5. Wang D, Moriggl R, Stravopodis D, Carpino N, Marine JC, Teglund S, Feng J, Ihle JN. EMBO J; 2000 Feb 01; 19(3):392-9. PubMed ID: 10654938 [Abstract] [Full Text] [Related]
4. CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation. Involvement of the ubiquitin proteasome pathway. Tauchi T, Yoshimura A, Ohyashiki K. Exp Hematol; 2001 Mar 01; 29(3):356-61. PubMed ID: 11274764 [Abstract] [Full Text] [Related]
5. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. Ram PA, Waxman DJ. J Biol Chem; 2000 Dec 15; 275(50):39487-96. PubMed ID: 10991939 [Abstract] [Full Text] [Related]
6. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Callus BA, Mathey-Prevot B. Blood; 1998 May 01; 91(9):3182-92. PubMed ID: 9558373 [Abstract] [Full Text] [Related]
7. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Mimnaugh EG, Chen HY, Davie JR, Celis JE, Neckers L. Biochemistry; 1997 Nov 25; 36(47):14418-29. PubMed ID: 9398160 [Abstract] [Full Text] [Related]
8. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. Schubert U, Antón LC, Bacík I, Cox JH, Bour S, Bennink JR, Orlowski M, Strebel K, Yewdell JW. J Virol; 1998 Mar 25; 72(3):2280-8. PubMed ID: 9499087 [Abstract] [Full Text] [Related]
9. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C. Blood; 2003 May 01; 101(9):3436-43. PubMed ID: 12506011 [Abstract] [Full Text] [Related]
10. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. Blood; 1997 May 01; 89(9):3148-54. PubMed ID: 9129017 [Abstract] [Full Text] [Related]
11. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Kim TK, Maniatis T. Science; 1996 Sep 20; 273(5282):1717-9. PubMed ID: 8781235 [Abstract] [Full Text] [Related]
12. Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes. Liu D, Scafidi J, Prada AE, Zahedi K, Davis AE. Biochem Biophys Res Commun; 2002 Dec 13; 299(4):574-80. PubMed ID: 12459177 [Abstract] [Full Text] [Related]
13. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin. Yen CH, Yang YC, Ruscetti SK, Kirken RA, Dai RM, Li CC. J Immunol; 2000 Dec 01; 165(11):6372-80. PubMed ID: 11086075 [Abstract] [Full Text] [Related]
14. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. Yu CL, Burakoff SJ. J Biol Chem; 1997 May 30; 272(22):14017-20. PubMed ID: 9162019 [Abstract] [Full Text] [Related]
15. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription. Goh EL, Zhu T, Leong WY, Lobie PE. Endocrinology; 2002 Sep 30; 143(9):3590-603. PubMed ID: 12193575 [Abstract] [Full Text] [Related]
16. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway. Okabe S, Tauchi T, Morita H, Ohashi H, Yoshimura A, Ohyashiki K. Exp Hematol; 1999 Oct 30; 27(10):1542-7. PubMed ID: 10517496 [Abstract] [Full Text] [Related]
17. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. Canu N, Barbato C, Ciotti MT, Serafino A, Dus L, Calissano P. J Neurosci; 2000 Jan 15; 20(2):589-99. PubMed ID: 10632588 [Abstract] [Full Text] [Related]
18. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Chin H, Nakamura N, Kamiyama R, Miyasaka N, Ihle JN, Miura O. Blood; 1996 Dec 15; 88(12):4415-25. PubMed ID: 8977232 [Abstract] [Full Text] [Related]
19. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. J Virol; 1999 Sep 15; 73(9):7231-40. PubMed ID: 10438810 [Abstract] [Full Text] [Related]
20. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal. Migone TS, Humbert M, Rascle A, Sanden D, D'Andrea A, Johnston JA. Blood; 2001 Sep 15; 98(6):1935-41. PubMed ID: 11535532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]